| P50 | author | Tatsuhiko Anzai | Q88134443 |
| P2093 | author name string | Michiko Watanabe | |
| | Mayumi Mochizuki | |
| | Kunihiko Takahashi | |
| | Atsuko Murashima | |
| P2860 | cites work | Management of epilepsy during pregnancy: an update | Q26752470 |
| | Psychotropic dose equivalence in Japan | Q28080652 |
| | Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase® | Q33167702 |
| | Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? | Q33940520 |
| | National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 |
| | Neonatal drug withdrawal | Q34250791 |
| | Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study | Q34702282 |
| | ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation | Q34766231 |
| | Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases | Q35754985 |
| | Drug Interactions at the Human Placenta: What is the Evidence? | Q36081992 |
| | Psychiatric disorders in pregnant and postpartum women in the United States | Q37158826 |
| | PROC LCA: A SAS Procedure for Latent Class Analysis | Q37445822 |
| | Gender issues in antiepileptic drug treatment | Q38213778 |
| | The importance of pharmacoepidemiology in pregnancy-implications for safety | Q38640575 |
| | Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug | Q38665970 |
| | Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. | Q40048446 |
| | Measuring diagnostic accuracy in the absence of a "gold standard". | Q40744492 |
| | Methodology for Estimating the Risk of Adverse Drug Reactions in Pregnant Women: Analysis of the Japanese Adverse Drug Event Report Database | Q40876124 |
| | Drug Use before and during Pregnancy in Japan: The Japan Environment and Children's Study. | Q41924443 |
| | Prescription drug use in pregnancy. | Q44333289 |
| | Impact of maternal depression on infant nutritional status and illness: a cohort study | Q47930895 |
| | Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database. | Q50919394 |
| | Trends in Polypharmacy in Japan: A Nationwide Retrospective Study | Q57020543 |
| | Antidepressants-related cardiovascular adverse events using the adverse event reporting system | Q57212670 |
| | Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database | Q58106965 |
| | Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births | Q59129888 |
| | Latent Class Analysis in health research | Q60587607 |
| | Psychotropic effects of antiepileptic drugs | Q62868812 |
| | Increasing use of antidepressants in pregnancy | Q80426520 |
| | Psychiatric disorders in pregnancy | Q83929788 |
| | Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) | Q89044428 |
| P433 | issue | 1 | |
| P304 | page(s) | 118 | |
| P577 | publication date | 2020-03-12 | |
| P1433 | published in | BMC Psychiatry | Q15750257 |
| P1476 | title | Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis | |
| P478 | volume | 20 | |